Bernd Jilma

Bernd Jilma's AcademicInfluence.com Rankings

Bernd Jilma

Computer Science

#5961

World Rank

#6286

Historical Rank

Machine Learning

#1780

World Rank

#1803

Historical Rank

Artificial Intelligence

#2026

World Rank

#2060

Historical Rank

Database

#3085

World Rank

#3215

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Bernd Jilma's Degrees

PhD Computer Science University of Vienna
Masters Computer Science University of Vienna
Bachelors Computer Science University of Vienna

Similar Degrees You Can Earn

Best Online PhD of Computer Science (Doctorates) 2026
Best Online Master's in Computer Science
10 Fastest Accelerated Online Bachelor's of Computer Science
Best Online Bachelor's in Computer Science 2026

Why Is Bernd Jilma Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Bernd Jilma's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel. (2009) (423)
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura. (2016) (396)
Von Willebrand Factor in Cardiovascular Disease: Focus on Acute Coronary Syndromes (2008) (350)
Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. (2004) (330)
Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans. (2000) (303)
Risk of venous thromboembolism in patients with COVID‐19: A systematic review and meta‐analysis (2020) (294)
Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction. (2001) (280)
Calcium channel blockers reduce the antiplatelet effect of clopidogrel (2008) (272)
Platelet Function Predicts Myocardial Damage in Patients With Acute Myocardial Infarction (2004) (246)
Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial (2015) (239)
Monitoring of Aspirin (ASA) Pharmacodynamics with the Platelet Function Analyzer PFA-100® (2000) (216)
A Proinflammatory State Is Detectable in Obese Children and Is Accompanied by Functional and Morphological Vascular Changes (2006) (211)
Paroxetine decreases platelet serotonin storage and platelet function in human beings (2000) (211)
Regulation of adhesion molecules during human endotoxemia. No acute effects of aspirin. (1999) (211)
Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial. (2015) (196)
Morphine decreases clopidogrel concentrations and effects: a randomized, double-blind, placebo-controlled trial. (2014) (194)
Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting. (2019) (191)
Challenges with advanced therapy medicinal products and how to meet them (2010) (191)
Interspecies differences in coagulation profile (2008) (174)
Effects of carbon monoxide inhalation during experimental endotoxemia in humans. (2005) (174)
Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial (2007) (171)
Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans (2006) (162)
Morning hypercoagulability and hypofibrinolysis. Diurnal variations in circulating activated factor VII, prothrombin fragment F1+2, and plasmin-plasmin inhibitor complex. (1997) (156)
Effect of proton pump inhibitors on clinical outcome in patients treated with clopidogrel: a systematic review and meta‐analysis (2010) (141)
Heparin blunts endotoxin-induced coagulation activation. (1999) (137)
Mitochondria Are a Subset of Extracellular Vesicles Released by Activated Monocytes and Induce Type I IFN and TNF Responses in Endothelial Cells. (2019) (136)
Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: a randomized, placebo controlled trial for dose optimization in 128 healthy subjects. (2006) (134)
Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin. (2003) (134)
Multiple electrode aggregometry predicts stent thrombosis better than the vasodilator‐stimulated phosphoprotein phosphorylation assay (2010) (131)
Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemia. (2003) (128)
Platelet dysfunction in outpatients with left ventricular assist devices. (2009) (125)
Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS (2006) (124)
Menstrual cycle-associated changes in blood levels of interleukin-6, alpha1 acid glycoprotein, and C-reactive protein. (1997) (122)
In vivo profile of the human leukocyte microRNA response to endotoxemia. (2009) (122)
Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation (2005) (120)
Elevated Circulating P-Selectin in Insulin Dependent Diabetes Mellitus (1996) (120)
Personalized antiplatelet treatment after percutaneous coronary intervention: the MADONNA study. (2013) (118)
Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases (2010) (118)
Thrombin as a multi-functional enzyme (2011) (112)
Sex differences in concentrations of exhaled nitric oxide and plasma nitrate. (1996) (111)
Evidence of a U‐shaped association between factor XII activity and overall survival (2007) (107)
Phenotyping vs. genotyping for prediction of clopidogrel efficacy and safety: the PEGASUS‐PCI study (2012) (104)
Altered platelet plug formation in hyperthyroidism and hypothyroidism. (2007) (103)
VWF excess and ADAMTS13 deficiency: a unifying pathomechanism linking inflammation to thrombosis in DIC, malaria, and TTP (2014) (99)
Effects of Endotoxemia on Thrombopoiesis in Men (1999) (96)
Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site (2017) (95)
Sex differences in HAART-associated dyslipidaemia (2001) (87)
Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine. (2008) (85)
Inhibition of von Willebrand factor by ARC1779 in patients with acute thrombotic thrombocytopenic purpura (2010) (83)
Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia (2004) (81)
Initial experience from a double‐blind, placebo‐controlled, clinical outcome study of ARC1779 in patients with thrombotic thrombocytopenic purpura (2012) (78)
Anticoagulant interventions in hospitalized patients with COVID‐19: A scoping review of randomized controlled trials and call for international collaboration (2020) (78)
Effects of endothelin-1 (ET-1) on ocular hemodynamics. (1997) (77)
High dose dexamethasone increases circulating P-selectin and von Willebrand factor levels in healthy men (2005) (77)
Impact of clopidogrel loading dose on clinical outcome in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis (2010) (76)
A dose ranging phase I/II trial of the von Willebrand factor inhibiting aptamer ARC1779 in patients with congenital thrombotic thrombo - cytopenic purpura (2011) (76)
Effects of desmopressin on circulating P‐selectin (1996) (76)
Targeting von Willebrand factor and platelet glycoprotein Ib receptor (2010) (74)
Differential in vivo activation of monocyte subsets during low-grade inflammation through experimental endotoxemia in humans (2016) (73)
Endotoxin-induced activation of the coagulation cascade in humans: effect of acetylsalicylic acid and acetaminophen. (1999) (73)
Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study. (2008) (73)
Pharmacodynamics of active site‐inhibited factor VIIa in endotoxin‐induced coagulation in humans (2002) (72)
A randomised pilot trial of the anti-von Willebrand factor aptamer ARC1779 in patients with type 2b von Willebrand disease (2010) (72)
Angiotensin Receptor Blockade Decreases Markers of Vascular Inflammation (2004) (72)
Acetaminophen has Greater Antipyretic Efficacy than Aspirin in Endotoxemia: A Randomized, Double‐Blind, Placebo‐Controlled Trial (1999) (71)
Impact of morphine on antiplatelet effects of oral P2Y12 receptor inhibitors. (2016) (69)
Lepirudin blunts endotoxin-induced coagulation activation. (2000) (69)
Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial. (2019) (69)
Pharmacokinetics, pharmacodynamics and safety of aptamers (2018) (68)
Morphine decreases ticagrelor concentrations but not its antiplatelet effects: a randomized trial in healthy volunteers (2016) (67)
Plasma protein profiling: Unique and stable features of individuals (2005) (67)
Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C. (2009) (67)
A Randomized Clinical Trial of Anti-IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection. (2020) (66)
Impaired Platelet Function among Platelet Donors (2001) (65)
Pharmacokinetics of Lopinavir and Ritonavir in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19) (2020) (65)
The interleukin-6 G(-174)C promoter polymorphism does not determine plasma interleukin-6 concentrations in experimental endotoxemia in humans. (2004) (65)
The aptamer ARC1779 is a potent and specific inhibitor of von willebrand factor mediated ex vivo platelet function in acute myocardial infarction (2009) (63)
Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups (2019) (62)
A randomized, placebo-controlled phase I study assessing the safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein OprF/I vaccine (IC43) in healthy volunteers (2014) (62)
Hemostasis in cardiac arrest patients treated with mild hypothermia initiated by cold fluids. (2009) (61)
Duffy antigen modifies the chemokine response in human endotoxemia (2008) (61)
Morphine interaction with prasugrel: a double-blind, cross-over trial in healthy volunteers (2015) (61)
A Randomized, Controlled Trial of the Effects of Adding Vitamin B12 and Folate to Erythropoietin for the Treatment of Anemia of Prematurity (2006) (61)
Role of von Willebrand factor in vascular disease (2009) (60)
Recombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemia (2006) (60)
Anti–von Willebrand factor aptamer ARC1779 for refractory thrombotic thrombocytopenic purpura (2009) (59)
Cross validation of the Multiple Electrode Aggregometry (2009) (58)
Fosinopril decreases levels of soluble vascular cell adhesion molecule-1 in borderline hypertensive type II diabetic patients with microalbuminuria. (1998) (58)
Evaluation of antiinflammatory and antiadhesive effects of heparins in human endotoxemia (2003) (58)
Safety, immunogenicity and dose response of VLA84, a new vaccine candidate against Clostridium difficile, in healthy volunteers. (2016) (57)
Effects of estradiol on circulating P-selectin. (1996) (57)
Endotoxaemia modulates Toll‐like receptors on leucocytes in humans (2003) (57)
Differential induction of P‐selectin expression on platelets by two cell separators during plateletpheresis and the effect of gender on the release of soluble P‐selectin (1998) (57)
Comparison of the Effects of Ketamine and Memantine on Prolactin and Cortisol Release in Men: A Randomized, Double-blind, Placebo-controlled Trial (2001) (56)
The single nucleotide polymorphism Ser128Arg in the E-selectin gene is associated with enhanced coagulation during human endotoxemia. (2005) (56)
Dexamethasone down‐regulates the expression of L‐selectin on the surface of neutrophils and lymphocytes in humans* (1997) (56)
Inhibition of tissue factor pathway inhibitor by the aptamer BAX499 improves clotting of hemophilic blood and plasma (2012) (56)
Sutimlimab in Cold Agglutinin Disease. (2021) (56)
Effect of Fortifiers and Additional Protein on the Osmolarity of Human Milk: Is It Still Safe for the Premature Infant? (2013) (55)
Effects of exercise on circulating vascular adhesion molecules in healthy men. (1997) (55)
Effects of nitric oxide on platelet activation during plateletpheresis and in vivo tracking of biotinylated platelets in humans (1999) (55)
Effects of 17 beta-estradiol on circulating adhesion molecules. (1994) (54)
The anti-von Willebrand factor aptamer ARC1779 increases von Willebrand factor levels and platelet counts in patients with type 2B von Willebrand disease (2012) (54)
Persistent elevation and metabolic dependence of circulating E-selectin after delivery in women with gestational diabetes mellitus. (1997) (54)
Fy phenotype and gender determine plasma levels of monocyte chemotactic protein (2001) (54)
Effects of enalapril and losartan on circulating adhesion molecules and monocyte chemotactic protein-1. (2002) (53)
ARC15105 Is a Potent Antagonist of Von Willebrand Factor Mediated Platelet Activation and Adhesion (2012) (53)
Immunogenicity and safety of different injection routes and schedules of IC41, a Hepatitis C virus (HCV) peptide vaccine. (2010) (52)
Anti‐C1s monoclonal antibody BIVV009 in late antibody‐mediated kidney allograft rejection—results from a first‐in‐patient phase 1 trial (2018) (51)
D-dimer and histamine in early stage bacteremia: A prospective controlled cohort study. (2015) (51)
The aptamer ARC1779 blocks von Willebrand factor–dependent platelet function in patients with thrombotic thrombocytopenic purpura ex vivo (2010) (51)
Circadian variation of granulocyte colony stimulating factor levels in man (1999) (50)
Effects of a Combined Therapy of Erythropoietin, Iron, Folate, and Vitamin B12 on the Transfusion Requirements of Extremely Low Birth Weight Infants (2006) (50)
Chikungunya vaccines in development (2015) (50)
Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. (2011) (50)
Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO®, IC51. (2011) (49)
Increased platelet aggregation and in vivo platelet activation after granulocyte colony-stimulating factor administration (2011) (48)
Expression of the High-Affinity IgG Receptor FcRI (CD64) in Patients With Inflammatory Bowel Disease: A New Biomarker for Gastroenterologic Diagnostics (2009) (46)
Procoagulant microparticles promote coagulation in a factor XI‐dependent manner in human endotoxemia (2016) (46)
Acquired von Willebrand factor deficiency caused by LVAD is ADAMTS-13 and platelet dependent. (2016) (46)
Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial (2019) (45)
Systemic inflammation increases shear stress‐induced platelet plug formation measured by the PFA‐100 (2000) (44)
Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51. (2008) (44)
Functional and phenotypic characterization of peptide-vaccine-induced HCV-specific CD8+ T cells in healthy individuals and chronic hepatitis C patients. (2007) (44)
Beneficial effects of protease inhibitors on body composition and energy expenditure: a comparison between HIV-infected and AIDS patients. (1999) (43)
Dual non-responsiveness to antiplatelet treatment is a stronger predictor of cardiac adverse events than isolated non-responsiveness to clopidogrel or aspirin. (2013) (42)
Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial. (2004) (42)
Partial Blockade of Nitric Oxide Synthase Blunts the Exercise-induced Increase of von Willebrand Factor Antigen and of Factor VIII in Man (1997) (41)
A pilot study on reparixin, a CXCR1/2 antagonist, to assess safety and efficacy in attenuating ischaemia–reperfusion injury and inflammation after on‐pump coronary artery bypass graft surgery (2015) (40)
The net clinical benefit of personalized antiplatelet therapy in patients undergoing percutaneous coronary intervention. (2015) (40)
Hypertensive emergencies are associated with elevated markers of inflammation, coagulation, platelet activation and fibrinolysis (2013) (40)
Changes in thrombopoiesis and platelet reactivity in extremely low birth weight infants undergoing erythropoietin therapy for treatment of anaemia of prematurity (2004) (39)
Small Volume Enemas Do Not Accelerate Meconium Evacuation in Very Low Birth Weight Infants (2007) (39)
Regulation of Fas (APO-1, CD95) and Fas Ligand Expression in Leukocytes During Systemic Inflammation in Humans (2003) (39)
The effect of antiplatelet drugs clopidogrel and aspirin is less immediately after stent implantation. (2009) (39)
A Randomized, First‐in‐Human, Healthy Volunteer Trial of sutimlimab, a Humanized Antibody for the Specific Inhibition of the Classical Complement Pathway (2018) (39)
Potential diagnostic markers for disseminated intravascular coagulation of sepsis. (2016) (38)
Pregnancy-associated diamine oxidase originates from extravillous trophoblasts and is decreased in early-onset preeclampsia (2018) (38)
Effects of aspirin and NO-aspirin (NCX 4016) on platelet function and coagulation in human endotoxemia (2010) (37)
The EGF A61G polymorphism is associated with disease-free period and survival in malignant melanoma. (2006) (37)
Measurement of the levels of reticulated platelets after plateletpheresis to monitor activity of thrombopoiesis (1998) (36)
Acenocoumarol decreases tissue factor–dependent coagulation during systemic inflammation in humans (2002) (36)
Levels of adhesion molecules do not decrease after 3 months of statin therapy in moderate hypercholesterolaemia. (2003) (36)
Simvastatin and rosuvastatin mobilize Endothelial Progenitor Cells but do not prevent their acute decrease during systemic inflammation. (2008) (36)
Regulation of protease-activated receptor 1 (PAR1) on platelets and responsiveness to thrombin receptor activating peptide (TRAP) during systemic inflammation in humans (2003) (36)
O-glycoside biomarker of apolipoprotein C3: responsiveness to obesity, bariatric surgery, and therapy with metformin, to chronic or severe liver disease and to mortality in severe sepsis and graft vs host disease. (2009) (35)
Endotoxin down-modulates granulocyte colony-stimulating factor receptor (CD114) on human neutrophils. (2000) (35)
Putative role of adhesion molecules in metabolic disorders. (1997) (35)
Human Milk Analyser shows that the lactation period affects protein levels in preterm breastmilk (2016) (35)
Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib (2016) (35)
Selective Targeting of a Disease-Related Conformational Isoform of Macrophage Migration Inhibitory Factor Ameliorates Inflammatory Conditions (2015) (34)
The Effect of an Osmotic Contrast Agent on Complete Meconium Evacuation in Preterm Infants (2012) (34)
Effects of low dose endotoxemia on endothelial progenitor cells in humans. (2007) (34)
Coagulation interventions in experimental human endotoxemia. (2006) (34)
Effects of angiotensin-II infusion at pressor and subpressor doses on endothelin-1 plasma levels in healthy men. (1997) (34)
Detecting aspirin resistance with the platelet function analyzer (PFA-100). (2001) (33)
Reproducibility and standardized reporting of the vasodilator-stimulated phosphoprotein phosphorylation assay (2008) (33)
Crushed sublingual versus oral ticagrelor administration strategies in patients with unstable angina (2017) (33)
Variable inhibition of high-shear-induced platelet plug formation by eptifibatide and tirofiban under conditions of platelet activation and high von Willebrand release: a randomized, placebo-controlled, clinical trial. (2004) (33)
Glucocorticoids dose-dependently increase plasma levels of granulocyte colony stimulating factor in man. (1998) (33)
Time lag in platelet function inhibition by clopidogrel in stroke patients as measured by PFA‐100 (2004) (33)
Efficacy of recombinant erythropoietin in autoimmune hemolytic anemia: a multicenter international study (2020) (33)
Massive pulmonary embolism leading to cardiac arrest is associated with consumptive coagulopathy presenting as disseminated intravascular coagulation (2010) (32)
Asphyxia by Drowning Induces Massive Bleeding Due To Hyperfibrinolytic Disseminated Intravascular Coagulation (2015) (32)
Racial differences in endotoxin‐induced tissue factor‐triggered coagulation (2009) (32)
Inhibition of Protease-Activated Receptor (PAR1) Reduces Activation of the Endothelium, Coagulation, Fibrinolysis and Inflammation during Human Endotoxemia (2018) (32)
Evaluation of coagulation markers for early diagnosis of acute coronary syndromes in the emergency room. (2002) (32)
Effects of anticoagulation on thrombopoietin release during endotoxemia. (2001) (32)
Homozygosity in the single nucleotide polymorphism Ser128Arg in the E-selectin gene associated with recurrent venous thromboembolism. (2006) (31)
Platelet function under high‐shear conditions from platelet concentrates (2007) (31)
Ethnic differences in plasma levels of interleukin-8 (IL-8) and granulocyte colony stimulating factor (G-CSF). (2007) (31)
Why have studies of tailored anti-platelet therapy failed so far? (2013) (31)
Abciximab as a bridging strategy to overcome morphine-prasugrel interaction in STEMI patients. (2016) (31)
Sublingual functional capillary rarefaction in chronic heart failure (2018) (30)
Safety analysis of a Vero-cell culture derived Japanese encephalitis vaccine, IXIARO (IC51), in 6 months of follow-up. (2010) (30)
Effect of Intradermal Tumor Necrosis Factor-α-induced Inflammation on Coagulation Factors in Dermal Vessel Endothelium (2001) (30)
Influence of angiotensin II on circulating adhesion molecules and blood leukocyte count in vivo. (1996) (30)
Human monocyte stimulation by experimental whole body hyperthermia. (2002) (30)
Safety issues of plateletpheresis: comparison of the effects of two cell separators on the activation of coagulation, fibrinolysis, and neutrophils and on the formation of neutrophil‐platelet aggregates (1999) (30)
Effects of heparin and aspirin on circulating P-selectin, E-selectin and von Willebrand Factor levels in healthy men. (2001) (30)
Topical azithromycin for the prevention of Lyme borreliosis: a randomised, placebo-controlled, phase 3 efficacy trial. (2017) (29)
Improved characteristics of aPC-resistance assay: Coatest aPC resistance by predilution of samples with factor V deficient plasma. (1996) (29)
Effect of factor X inhibition on coagulation activation and cytokine induction in human systemic inflammation. (2002) (29)
Single, very low rituximab doses in healthy volunteers - a pilot and a randomized trial: implications for dosing and biosimilarity testing (2018) (29)
Targeting von Willebrand Factor in Ischaemic Stroke: Focus on Clinical Evidence (2018) (29)
High levels of reticulated platelets and thrombopoietin characterize fetal thrombopoiesis (2001) (29)
The development and characterization of a long acting anti‐thrombotic von Willebrand factor (VWF) aptamer (2020) (28)
Evaluation of bedside prothrombin time and activated partial thromboplastin time measurement by coagulation analyzer CoaguCheck Plus in various clinical settings. (1997) (28)
Reversal strategy in antagonizing the P2Y12‐inhibitor ticagrelor (2013) (28)
Marked increase in vascular endothelial growth factor concentrations during Escherichia coli endotoxin‐induced acute inflammation in humans (2003) (28)
Glycoprotein Ib polymorphisms influence platelet plug formation under high shear rates (2003) (28)
Rationale and Design of the Effectiveness of LowEr maintenanCe dose of TicagRelor early After myocardial infarction (ELECTRA) pilot study. (2018) (28)
In-vivo effects of simvastatin and rosuvastatin on global gene expression in peripheral blood leucocytes in a human inflammation model (2008) (27)
Sex differences in the association between albumin and all‐cause and vascular mortality (2009) (27)
THE TUMOR NECROSIS FACTOR &agr; −308 G/A POLYMORPHISM DOES NOT INFLUENCE INFLAMMATION AND COAGULATION RESPONSE IN HUMAN ENDOTOXEMIA (2007) (27)
Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study of the Penetration of a Monoclonal Antibody Combination (ASN100) Targeting Staphylococcus aureus Cytotoxins in the Lung Epithelial Lining Fluid of Healthy Volunteers (2019) (27)
Influence of the Duffy Antigen on Pharmacokinetics and Pharmacodynamics of Recombinant Monocyte Chemoattractant Protein (MCP-1, CCL-2) in Vivo (2009) (27)
The C-reactive protein (+)1444C/T alteration modulates the inflammation and coagulation response in human endotoxemia. (2006) (27)
Effects of histamine and nitric oxide synthase inhibition on plasma levels of von Willebrand factor antigen. (1998) (27)
Quantification of human diamine oxidase. (2017) (27)
Pronounced platelet hyperfunction in patients with cardiac arrest achieving restoration of spontaneous circulation* (2009) (26)
Effects of hyperinsulinemia on plasma levels of circulating adhesion molecules. (2000) (26)
Interplay between Genetic and Clinical Variables Affecting Platelet Reactivity and Cardiac Adverse Events in Patients Undergoing Percutaneous Coronary Intervention (2014) (26)
Effects of prasugrel on platelet inhibition during systemic endotoxaemia: a randomized controlled trial. (2012) (26)
The Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms influence the late inflammatory response in human endotoxemia. (2005) (26)
A first-in-human study of PDC31 (prostaglandin F2α receptor inhibitor) in primary dysmenorrhea. (2014) (25)
Combined integrated protocol/basket trial design for a first-in-human trial (2016) (25)
Colistin Reduces LPS‐Triggered Inflammation in a Human Sepsis Model In Vivo: A Randomized Controlled Trial (2017) (25)
Massive release of the histamine‐degrading enzyme diamine oxidase during severe anaphylaxis in mastocytosis patients (2019) (25)
Evaluation of a new screening assay ProC Global for identification of defects in the protein C/protein S anticoagulant pathway. (1997) (25)
Hydroxychloroquine versus lopinavir/ritonavir in severe COVID-19 patients (2020) (24)
LPS-induced microvascular leukocytosis can be assessed by blue-field entoptic phenomenon. (2004) (24)
In vitro platelet function of platelet concentrates prepared using three different apheresis devices determined by impedance and optical aggregometry (2009) (24)
Blockade of GPIIb/IIIa by eptifibatide and tirofiban does not alter tissue factor induced thrombin generation in human endotoxemia (2003) (24)
Cold agglutinin disease: current challenges and future prospects (2019) (24)
Specific inhibition of the classical complement pathway prevents C3 deposition along the dermal-epidermal junction in bullous pemphigoid. (2019) (24)
Dynamic assessment of venous thromboembolism risk in patients with cancer by longitudinal D‐Dimer analysis: A prospective study (2020) (24)
Endotoxin Down-Modulates P-Selectin Glycoprotein Ligand-1 (PSGL-1, CD162) on Neutrophils in Humans (2004) (24)
A short-chain methotrexate polyglutamate as outcome parameter in rheumatoid arthritis patients receiving methotrexate. (2012) (23)
Reparixin, a Specific Interleukin-8 Inhibitor, Has No Effects on Inflammation during Endotoxemia (2007) (23)
Risk factors cannot explain the higher prevalence rates of precancerous colorectal lesions in men (2016) (23)
Surface cooling for induction of mild hypothermia in conscious healthy volunteers - a feasibility trial (2011) (22)
A randomized, double-blind, parallel, single-site pilot trial to compare two different starting doses of methotrexate in methotrexate-naïve adult patients with rheumatoid arthritis. (2012) (22)
Product review on the JE vaccine IXIARO (2015) (22)
Elevated numbers of reticulated platelets in hyperthyroidism: direct evidence for an increase of thrombopoiesis (1998) (22)
Dexamethasone lowers circulating E-selectin and ICAM-1 in healthy men. (2000) (22)
Plasmatic tissue factor pathway inhibitor is a major determinant of clotting in factor VIII inhibited plasma or blood (2013) (22)
Plasma Levels of Activated Factor VII Decrease during the Menstrual Cycle (1998) (22)
Early Effects of Paroxetine on Serotonin Storage, Plasma Levels, and Urinary Excretion: A Randomized, Double-Blind, Placebo-Controlled Trial (2004) (22)
Effects of granulocyte colony stimulating factor on retinal leukocyte and erythrocyte flux in the human retina. (2002) (22)
Safety, tolerability, and immunogenicity of a recombinant toxic shock syndrome toxin (rTSST)-1 variant vaccine: a randomised, double-blind, adjuvant-controlled, dose escalation first-in-man trial. (2016) (21)
Systemic inflammation increases shear stress-induced platelet plug formation measured by the PFA-100 (2000) (21)
Platelet inhibition with standard vs. lower maintenance dose of ticagrelor early after myocardial infarction (ELECTRA): a randomized, open-label, active-controlled pharmacodynamic and pharmacokinetic study. (2019) (21)
Clopidogrel in Critically Ill Patients (2017) (21)
Inhibition of complement C1s in patients with cold agglutinin disease: lessons learned from a named patient program. (2020) (21)
Granulocyte colony‐stimulating factor (G‐CSF) downregulates its receptor (CD114) on neutrophils and induces gelatinase B release in humans (2000) (21)
The influence of methotrexate on the gene expression of the pro-inflammatory cytokine IL-12A in the therapy of rheumatoid arthritis. (2011) (21)
Dissociation between systemic and pulmonary anti‐inflammatory effects of dexamethasone in humans (2016) (20)
Anti-cardiolipin antibodies and overall survival in a large cohort: preliminary report. (2006) (20)
Potent irreversible P2Y12 inhibition does not reduce LPS-induced coagulation activation in a randomized, double-blind, placebo-controlled trial. (2016) (20)
Ticagrelor: from discovery to Phase III clinical trial. (2010) (20)
An update on the clinical evidence that supports biosimilar approvals in Europe (2018) (20)
Chondroitin Sulfate N‐acetylgalactosaminyltransferase‐1 (CSGalNAcT‐1) Deficiency Results in a Mild Skeletal Dysplasia and Joint Laxity (2017) (20)
Clinical trials for authorized biosimilars in the European Union: a systematic review (2016) (20)
Characterization of recombinant human diamine oxidase (rhDAO) produced in Chinese Hamster Ovary (CHO) cells. (2016) (19)
Glycocalyx as Possible Limiting Factor in COVID-19 (2021) (19)
ELISA detection of MPO-DNA complexes in human plasma is error-prone and yields limited information on neutrophil extracellular traps formed in vivo (2021) (19)
Does Visceral Osteopathic Treatment Accelerate Meconium Passage in Very Low Birth Weight Infants?- A Prospective Randomized Controlled Trial (2015) (19)
Response to Letter by van Werkum: Proton pump inhibitors and clopidogrel: a difficult dilemma (2009) (19)
Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial (2022) (19)
Comparison between the impact of morning and evening doses of rivaroxaban on the circadian endogenous coagulation rhythm in healthy subjects (2016) (19)
Partial inhibition of nitric oxide synthase primes the stimulated pathway of vWF-secretion in man. (2000) (19)
Synergistic antiplatelet effects of clopidogrel and aspirin detected with the PFA-100 in stroke patients. (2003) (19)
MMP-8 Genotypes Influence the Inflammatory Response in Human Endotoxemia (2013) (19)
Cardiovascular Outcome in Patients Treated With SGLT2 Inhibitors for Heart Failure: A Meta-Analysis (2021) (18)
Single dose granulocyte colony-stimulating factor markedly enhances shear-dependent platelet function in humans (2010) (18)
Recovery, safety, and tolerability of a solvent/detergent‐treated and prion‐safeguarded transfusion plasma in a randomized, crossover, clinical trial in healthy volunteers (2013) (18)
Platelet hyperfunction is decreased by additional aspirin loading in patients presenting with myocardial infarction on daily aspirin therapy (2010) (18)
Troponin T predicts in-hospital and 1-year mortality in patients with pulmonary embolism (2009) (18)
Platelet activation at the onset of human endotoxemia is undetectable in vivo (2016) (18)
Neutrophil-Mediated Proteolysis of Thrombospondin-1 Promotes Platelet Adhesion and String Formation (2018) (18)
Studying multiple protein profiles over time to assess biomarker validity (2006) (17)
The effects of supra-normal protein C levels on markers of coagulation, fibrinolysis and inflammation in a human model of endotoxemia (2005) (17)
Rapid down modulation of P‐selectin glycoprotein ligand‐1 (PSGL‐1, CD162) by G–CSF in humans (2002) (17)
The effect of erythropoietin on platelet and endothelial activation markers: A prospective trial in healthy volunteers (2012) (17)
Disseminated intravascular coagulation in heat stroke: a hot topic. (2012) (17)
Starting enteral nutrition with preterm single donor milk instead of formula affects time to full enteral feeding in very low birthweight infants (2017) (17)
Immunogenicity and safety of the inactivated Japanese encephalitis vaccine IXIARO® in elderly subjects: Open-label, uncontrolled, multi-center, phase 4 study. (2016) (17)
Antithrombotic therapy in special circumstances. II—In children, thrombophilia, and miscellaneous conditions (2003) (17)
Heparin lowers plasma levels of activated factor VII (1999) (17)
Adverse Outcome in COVID-19 Is Associated With an Aggravating Hypo-Responsive Platelet Phenotype (2021) (16)
Procoagulant extracellular vesicles in amniotic fluid (2017) (16)
Anticoagulant Treatment Regimens in Patients With Covid‐19: A Meta‐Analysis (2021) (16)
Evidence against an effect of endothelin-1 on blood coagulation, fibrinolysis, and endothelial cell integrity in healthy men. (1997) (16)
Effects of endothelin‐1 on circulating adhesion molecules in man (1997) (16)
Dipyridamole Decreases Protease-Activated Receptor and Annexin-V Binding on Platelets of Poststroke Patients with Aspirin Nonresponsiveness (2006) (16)
Age and sex modulate metabolic and cardiovascular risk markers of patients after 1 year of highly active antiretroviral therapy (HAART). (2006) (16)
Granulocyte colony-stimulating factor (G-CSF) increases histone-complexed DNA plasma levels in healthy volunteers (2016) (16)
Natural IgM antibodies inhibit microvesicle-driven coagulation and thrombosis. (2020) (16)
Bridging the Missing Link with Emicizumab: A Bispecific Antibody for Treatment of Hemophilia A (2020) (16)
The aptamer BT200 blocks von Willebrand factor and platelet function in blood of stroke patients (2020) (16)
Additive effects between platelet concentrates and desmopressin in antagonizing the platelet glycoprotein IIb/IIIa inhibitor eptifibatide (2005) (15)
Short‐ and long‐term effects of therapy with interferon‐α and pegylated interferon‐α/ribavirin on platelet plug formation and von Willebrand factor release in patients with chronic hepatitis C (2005) (15)
Immunomodulatory effects of fosfomycin in an endotoxin model in human blood. (2006) (15)
The fibrinogen -148 C/T polymorphism influences inflammatory response in experimental endotoxemia in vivo. (2007) (15)
Anti Von Willebrand Factor Aptamer ARC 1779 for Refractory Thrombotic Thrombocytopenic Purpura. (2008) (15)
Pharmacokinetics and pharmacodynamics of BIBT 986, a novel small molecule dual inhibitor of thrombin and factor Xa (2006) (15)
Endotoxemia, inflammation, and atrial fibrillation. (2007) (15)
Enalapril Does Not Alter Adhesion Molecule Levels in Human Endotoxemia (2003) (15)
Convalescent Plasma Treatment in Patients with Covid-19: A Systematic Review and Meta-Analysis (2022) (15)
Rhabdomyolysis Following Ad26.COV2.S COVID-19 Vaccination (2021) (14)
Prasugrel in critically ill patients (2017) (14)
EFFECTS OF THE PAN-SELECTIN ANTAGONIST BIMOSIAMOSE (TBC1269) IN EXPERIMENTAL HUMAN ENDOTOXEMIA (2007) (14)
The aptamer BT200 effectively inhibits von Willebrand factor (VWF) dependent platelet function after stimulated VWF release by desmopressin or endotoxin (2020) (14)
Therapeutic approaches in the management of oral cyclosporine A intoxication. (2003) (14)
Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera From Subjects Dosed With the Anti-C1s Monoclonal Antibody TNT009—Results from a Randomized First-in-Human Phase 1 Trial (2017) (14)
Enhanced blood coagulation and enhanced fibrinolysis during hemodialysis with prostacyclin. (1997) (14)
Increased Fibrinolysis as a Specific Marker of Poor Outcome After Cardiac Arrest (2018) (14)
Assessment of platelets and the endothelium in patients presenting with acute coronary syndromes – is there a future? (2009) (14)
Kinetics of circulating selectin levels during bone marrow aplasia (1998) (14)
Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study (2019) (14)
Polymorphism in the tissue factor region is associated with basal but not endotoxin‐induced tissue factor‐mRNA levels in leukocytes (2006) (14)
Platelet Phenotype Analysis of COVID-19 Patients Reveals Progressive Changes in the Activation of Integrin αIIbβ3, F13A1, the SARS-CoV-2 Target EIF4A1 and Annexin A5 (2021) (14)
Studies on the effect of short‐term oral dihydroergotamine and troxerutin in patients with varicose veins (1994) (14)
Penetration of a Monoclonal Antibody Combination (ASN100) Targeting S. aureus Cytotoxins in Lung Epithelial Lining Fluid: A Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study in Healthy Volunteers. (2019) (14)
Antithrombotic therapy in special circumstances. I—pregnancy and cancer (2003) (14)
Simultaneous determination of acetylsalicylic acid and salicylic acid in human plasma by isocratic high-pressure liquid chromatography with post-column hydrolysis and fluorescence detection. (2013) (14)
Randomized clinical trials towards a single‐visit cure for chronic hepatitis C: Oral GSK2878175 and injectable RG‐101 in chronic hepatitis C patients and long‐acting injectable GSK2878175 in healthy participants (2020) (13)
Association of ABO blood group with bleeding severity in patients with bleeding of unknown cause. (2020) (13)
Von Willebrand factor antigen levels predict major adverse cardiovascular events in patients with carotid stenosis of the ICARAS study. (2019) (13)
Erythropoietin Treatment Is Associated with More Severe Thrombocytopenia in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy (2006) (13)
Potent and rapid reversal of the von Willebrand factor inhibitor aptamer BT200 (2020) (13)
Myeloid but not epithelial tissue factor exerts protective anti‐inflammatory effects in acid aspiration‐induced acute lung injury (2017) (13)
Validation of a novel tissue factor assay in experimental human endotoxemia. (2003) (13)
Effects of SGLT2 Inhibitors on Ion Homeostasis and Oxidative Stress associated Mechanisms in Heart Failure. (2021) (13)
Statistical analysis of Goal Attainment Scaling endpoints in randomised trials (2018) (13)
Antiplatelet Activity During Coadministration of the Selective Serotonin Reuptake Inhibitor Paroxetine and Aspirin in Male Smokers: A Randomized, Placebo‐Controlled, Double‐blind Trial (2006) (13)
Effects of nitroglycerin and sodium nitroprusside on endexpiratory concentrations of nitric oxide in healthy humans. (1998) (12)
Complement C1s inhibition with sutimlimab results in durable response in cold agglutinin disease: CARDINAL study 1-year interim follow-up results (2022) (12)
Rofecoxib exerts no effect on platelet plug formation in healthy volunteers. (2003) (12)
Cross validation of aspirin effect in healthy individuals by Impact-R and PFA-100: A double blind randomized placebo controlled trial (2009) (12)
Immunoglobulin administration to fetuses with anemia due to alloimmunization to D (1999) (12)
Effect of preanalytical time-delay on platelet function as measured by multiplate, PFA-100 and VerifyNow (2016) (12)
Vaccine against toxic shock syndrome in a first-in-man clinical trial (2017) (12)
Potential biomarkers of an exaggerated response to endotoxemia (2007) (12)
Added value of the DIC score and of D-dimer to predict outcome after successfully resuscitated out-of-hospital cardiac arrest. (2018) (12)
A Novel Diagnostic and Prognostic Score for Abdominal Aortic Aneurysms Based on D-Dimer and a Comprehensive Analysis of Myeloid Cell Parameters (2019) (12)
Low-molecular-weight heparin use in coronavirus disease 2019 is associated with curtailed viral persistence: a retrospective multicentre observational study (2021) (12)
Decreased renal function in hypertensive emergencies (2014) (12)
Sublingual microvasculature in diabetic patients. (2019) (12)
Absorption kinetics of low‐dose chewable aspirin – implications for acute coronary syndromes (2015) (11)
Functional capillary impairment in patients with ventricular assist devices (2019) (11)
Effects of testosterone suppression on serum levels of hepatitis B surface antigen and HBV-DNA in men. (2008) (11)
Current developments in anti-platelet therapy (2006) (11)
Endotoxemia enhances circulating endothelial cells in humans (2006) (11)
An experimental model to study isolated effects of thrombin in vivo. (2010) (11)
Inhibitory activity of aspirin on von Willebrand factor-induced platelet aggregation. (2000) (11)
Pharmacokinetics and Pharmacodynamics of the Dual FII/FX Inhibitor BIBT 986 in Endotoxin‐induced Coagulation (2007) (11)
Strain differences in toxic effects of long-lasting isoflurane anaesthesia between Wistar rats and Sprague Dawley rats. (2008) (11)
Acute effects of hyperglycaemia on plasma concentration of soluble P-selectin and von Willebrand factor in healthy volunteers -a prospective randomised double blind controlled study. (2009) (11)
Evaluation of anti-inflammatory and anti-adhesive effects of heparins in human endotoxemia (2002) (10)
Factor V Leiden mutation enhances fibrin formation and dissolution in vivo in a human endotoxemia model. (2010) (10)
Sutimlimab for treatment of cold agglutinin disease: why, how and for whom? (2022) (10)
Use of not authorised stem-cell based products: The Committe for Advanced Therapies (CAT) perspective (2010) (10)
The pharmacokinetics and pharmacodynamics of a new sustained-release leuprolide acetate depot compared to market references. (2008) (10)
Long Term Efficacy, Safety and PK/PD Profile of the Anti-C1s Antibody (BIVV009) in Primary Cold Agglutinin Disease Patients (2017) (10)
Oligomannosidic glycans at Asn-110 are essential for secretion of human diamine oxidase (2017) (10)
Clinical Experience With Numeta in Preterm Infants: Impact on Nutrient Intake and Costs. (2016) (10)
Physiochemical properties, safety and pharmacokinetics of bimosiamose disodium after intravenous administration. (2005) (10)
Biometry of the corpus callosum assessed by 3D ultrasound and its correlation to neurodevelopmental outcome in very low birth weight infants (2017) (10)
Safety of a universal, virus‐inactivated and prion‐depleted, pharmaceutical‐quality plasma: a randomized, double‐blind, clinical trial in healthy volunteers (2011) (10)
Prolonged antithrombotic therapy in patients after acute coronary syndrome: A critical appraisal of current European Society of Cardiology guidelines. (2020) (10)
In Vivo Study of the Effect of Exogenous Estradiol on α-Adrenoceptor Responsiveness of Human Veins (1994) (10)
Effects of sodium nitroprusside on hemodialysis-induced platelet activation. (1999) (10)
Sex differences in circulating P-selectin, E-selectin and thrombomodulin. (1996) (10)
Top‐down proteomic analysis by MALDI‐TOF profiling: Concentration‐independent biomarkers (2008) (10)
Prognosis of overt disseminated intravascular coagulation in patients admitted to a medical emergency department (2017) (10)
Effects of endothelin-1 and phenylephrine on plasma levels of von Willebrand factor and protein S. (2010) (10)
Interleukin-6 in acute coronary syndrome is a powerful predictor of long-term cardiovascular mortality. (2020) (9)
Establishment of a Low Dose Canine Endotoxemia Model to Test Anti-Inflammatory Drugs: Effects of Prednisolone (2013) (9)
Different Heparin Contents in Prothrombin Complex Concentrates May Impair Blood Clotting in Outpatients With Ventricular Assist Devices Receiving Phenprocoumon. (2016) (9)
Growth, Feeding Tolerance and Metabolism in Extreme Preterm Infants under an Exclusive Human Milk Diet (2019) (9)
Granulocyte colony-stimulating factor (G-CSF) downregulates its receptor (CD114) on neutrophils and induces gelatinase B release in humans. (2000) (9)
Evaluation of between-, within- and day-to-day variation of coagulation measured by rotational thrombelastometry (ROTEM) (2017) (9)
The ISTH DIC score predicts outcome in non-septic patients admitted to a cardiovascular intensive care unit. (2020) (9)
Endotoxemia enhances expression of the signaling receptor (GP130) on protein and molecular level. (2005) (9)
Tolerability and pharmacokinetics of inhaled bimosiamose disodium in healthy males. (2007) (9)
Does acute alcohol intoxication cause transaminase elevations in children and adolescents? (2016) (9)
High Platelet Reactivity after Transition from Cangrelor to Ticagrelor in Hypothermic Cardiac Arrest Survivors with ST-Segment Elevation Myocardial Infarction (2020) (8)
A MicroRNA Next-Generation-Sequencing Discovery Assay (miND) for Genome-Scale Analysis and Absolute Quantitation of Circulating MicroRNA Biomarkers (2022) (8)
Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera from Subjects Dosed with the Anti-C1s Monoclonal Antibody TNT009 - Results from a Randomized First-in-Human Phase 1 Trial. (2017) (8)
Colistin dampens fibrinolysis and endothelial activation during endotoxaemia (2017) (8)
Dexamethasone inhibits endotoxin‐induced coagulopathy in human lungs (2016) (8)
Demonstration of Clinical Comparability of the Biosimilar Filgrastim to Neupogen, in Terms of Safety and Efficacy, in Healthy Volunteers and Patients Receiving Myelosuppressive Chemotherapy (2014) (8)
High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19 (2021) (8)
Towards the development of specific antidotes: Idarucizumab for reversal of dabigatran effects (2015) (8)
Morphine Interaction with Aspirin: a Double-Blind, Crossover Trial in Healthy Volunteers (2018) (8)
A new flow cytometric method for simultaneous measurement of residual platelets and RBCs in plasma: validation and application for QC (2001) (8)
First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers (2022) (8)
COVID-19 is not “just another flu”: a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, Austria (2021) (7)
Further Evaluation of Pro-Atherogenic and Anti-Angiogenic Effects of Nilotinib in Mice and in Patients with Ph-Chromosome plus CML (2014) (7)
Increased Citrullinated Histone H3 Levels in the Early Post-Resuscitative Period Are Associated with Poor Neurologic Function in Cardiac Arrest Survivors—A Prospective Observational Study (2019) (7)
Aspirin. Methods to assess aspirin resistance. (2004) (7)
The use of frozen plasma samples in thromboelastometry (2017) (7)
Emerging drugs for antibody-mediated rejection after kidney transplantation: a focus on phase II & III trials (2022) (7)
The inflammatory response is influenced by FXIII VAL 34 LEU polymorphism in a human LPS model (2009) (7)
Pharmacokinetics and pharmacodynamics of the dual FII/FX inhibitor BIBT 986 in endotoxin-induced coagulation (2007) (7)
Genetic variations and their influence on risk and treatment of venous thrombosis. (2008) (7)
Interdependence between osteoprotegerin and active von Willebrand factor in long-term cardiovascular mortality prediction in patients undergoing percutaneous coronary intervention (2017) (7)
The proportion of reticulated platelets is higher in bone marrow than in peripheral blood in haematological patients (1999) (7)
Comparative proteomics reveals unexpected quantitative phosphorylation differences linked to platelet activation state (2019) (7)
Androgen deprivation decreases prostate specific antigen in the absence of tumor: implications for interpretation of PSA results (2013) (7)
Routine haematological parameters in COVID-19 prognosis (2020) (7)
von Willebrand Factor Predicts Mortality in ACS Patients Treated with Potent P2Y12 Antagonists and is Inhibited by Aptamer BT200 Ex Vivo (2020) (7)
Function of platelets in apheresis platelet concentrates and in patient blood after transfusion as assessed by Impact‐R (2009) (7)
Anti‐interleukin‐6 antibody clazakizumab in late antibody‐mediated kidney transplant rejection: effect on cytochrome P450 drug metabolism (2021) (7)
Ticagrelor and prasugrel are independent predictors of improved long‐term survival in ACS patients (2020) (6)
Comparison of a new ELISA-based with the flow cytometric assay for vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation to assess P2Y12 -inhibition after ticagrelor intake. (2013) (6)
Pharmacokinetics (PK) of S/D treated anti-D immunoglobulin after intramuscular injection in healthy volunteers: gender differences in PK. (2005) (6)
Sample Size for Multiple Hypothesis Testing in Biosimilar Development (2018) (6)
The von Willebrand factor A-1 domain binding aptamer BT200 elevates plasma levels of von Willebrand factor and factor VIII: a first-in-human trial (2021) (6)
Recombinant human diamine oxidase activity is not inhibited by ethanol, acetaldehyde, disulfiram, diethyldithiocarbamate or cyanamide. (2016) (6)
Antiviral therapy decreases GpIIb/IIIa activation of platelets in patients with chronic hepatitis C (2006) (6)
Response to vWF‐coated beads and soluble p‐selectin to characterize apheresis platelets: a comparison of three cell separators (2002) (6)
Tranexamic acid and fibrinogen restore clotting in vitro and in vivo in cardiac thrombus associated hyperfibrinolysis with overt bleedings (2014) (6)
Microarray-based Detection of Allergen-Reactive IgE in Patients with Mastocytosis. (2020) (6)
Identification of a novel exon encoding the amino-terminus of the predominant caspase-5 variants. (2006) (6)
Interleukin-6 level is a powerful predictor of long-term cardiovascular mortality in patients with acute coronary syndrome (2020) (6)
Defibrotide enhances fibrinolysis in human endotoxemia – a randomized, double blind, crossover trial in healthy volunteers (2019) (6)
DESMOPRESSIN AND PLATELETS ANTAGONIZE THE IN VITRO PLATELET DYSFUNCTION INDUCED BY GPIIb / IIIa INHIBITORS AND ASPIRIN 1 (2003) (6)
Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Percutaneous Coronary Intervention: A Meta‐Analysis (2021) (6)
Prevalence and Clinical Impact of Reduced Coagulation Factor XII Activity in Patients Receiving Extracorporeal Membrane Oxygenation (2021) (6)
Sustained sutimlimab response for 3 years in patients with cold agglutinin disease: A phase I, open‐label, extension trial (2022) (6)
Heparin-binding motif mutations of human diamine oxidase allow the development of a first-in-class histamine-degrading biopharmaceutical (2021) (6)
Age Related Differences in Monocyte Subsets and Cytokine Pattern during Acute COVID-19—A Prospective Observational Longitudinal Study (2021) (5)
Cardiovascular Scoring and Age-Related Mutations Predict the Occurrence of Adverse Vascular Events in CML Patients during Nilotinib Therapy (2017) (5)
Ex vivo properties of plasma clot formation and lysis in patients with cancer at risk for venous thromboembolism, arterial thrombosis, and death. (2020) (5)
A rapid, sensitive, and specific assay to measure TF activity based on chromogenic determination of thrombin generation (2021) (5)
Therapeutic failure or resistance to aspirin. (2004) (5)
Comparison of a new ELISA‐based with the flow cytometric assay for vasodilator‐associated stimulated phosphoprotein phosphorylation to assess P2Y12‐inhibition after ticagrelor intake (2013) (5)
Upregulation of cytokine mRNA in circulating leukocytes during human endotoxemia (2017) (5)
Acetylsalicylic acid in critically ill patients: a cross‐sectional and a randomized trial (2017) (5)
The pharmacokinetics of subcutaneously injected bimosiamose disodium in healthy male volunteers (2007) (5)
Platelets and new antiplatelet drugs (2005) (5)
Inhibition of Complement C1s By Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Efficacy and Safety Results from the Randomized, Placebo-Controlled Phase 3 CADENZA Study (2021) (5)
The effect of plasma removal from apheresis platelet concentrates on platelet function (2012) (5)
Differential Osteoprotegerin Kinetics after Stimulation with Desmopressin and Lipopolysaccharides In Vivo (2020) (5)
Sunday, 26 August 2012 (2012) (5)
Tecarfarin: A Novel Vitamin K Antagonist (2017) (5)
Dexamethasone Downregulates l-Selectin In Vitro and In Vivo (1998) (5)
ELBW infants receive inadvertent sodium load above the recommended intake (2020) (5)
A Model Predicting Mortality of Hospitalized Covid-19 Patients Four Days After Admission: Development, Internal and Temporal-External Validation (2022) (5)
Continuous thrombin infusion leads to a bleeding phenotype in sheep. (2012) (5)
Limitations of a calibrated, quantitative APC‐R assay under routine conditions (2020) (5)
ABC of antithrombotic therapy: Antithrombotic therapy in special circumstances. I—pregnancy and cancer (2003) (4)
The aptamer BT200 effectively inhibits von Willebrand factor (VWF) dependent platelet function after stimulated VWF release by desmopressin or endotoxin (2019) (4)
Platelets and Antiplatelet Medication in COVID-19-Related Thrombotic Complications (2022) (4)
Interference in specialized coagulation assays affecting the protein C pathway: Effects of marked haemolysis, hyperbilirubinaemia and lipaemia on chromogenic and clotting tests on two coagulation platforms (2019) (4)
Low-dose ticagrelor with or without acetylsalicylic acid in patients with acute coronary syndrome: Rationale and design of the ELECTRA-SIRIO 2 trial (2021) (4)
Clinical pharmacology of antiplatelet drugs (2022) (4)
Safety, tolerability, pharmacokinetics and pharmacodynamics of parenterally administered dutogliptin: A prospective dose‐escalating trial (2020) (4)
Platelet function in mitochondriopathy with stroke and stroke-like episodes (2004) (4)
Serum and Lung Pharmacokinetics of ASN100, a Monoclonal Antibody Combination for the Prevention and Treatment of Staphylococcus aureus Pneumonia (2017) (4)
Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trial (2022) (4)
The association of the Thr715Pro P‐selectin genotype with levels of P‐selectin in platelet concentrates (2014) (4)
Development of Advanced Therapy Medicinal Products: A Case for Early Scientific Advice (2010) (4)
Does Phosphodiesterase III Inhibition Reverse the Cardiodepressive Effects of Propofol? (1997) (4)
Simple, sensitive and specific quantification of diamine oxidase activity in complex matrices using newly discovered fluorophores derived from natural substrates (2020) (4)
Development and external validation of a logistic regression derived formula based on repeated routine hematological measurements predicting survival of hospitalized Covid-19 patients (2020) (4)
Point of care measurement of lepirudin and heparin anticoagulation during systemic inflammation. (2002) (4)
A phase III randomized, multicentre, double blind, active controlled trial to compare the efficacy and safety of two different anagrelide formulations in patients with essential thrombocythaemia – the TEAM‐ET 2·0 trial (2019) (4)
A Randomized, Double-Blind, Placebo-Controlled, Clinical Outcome Study of ARC1779 In Patients with Thrombotic Thrombocytopenic Purpura (TTP) (2010) (4)
False‐positive pregnancy test after transfusion of solvent/detergent‐treated plasma (2017) (4)
Aerosolized lancovutide in adolescents (≥12 years) and adults with cystic fibrosis - a randomized trial. (2020) (4)
Association between the rs342293 polymorphism and adverse cardiac events in patients undergoing percutaneous coronary intervention (2014) (4)
Female gender, menstrual cycle and estradiol affect plasma levels of monocyte chemotactic protein-1 (MCP-1) in humans. (2002) (4)
High Titer Persistent Neutralizing Antibodies Induced by TSST-1 Variant Vaccine Against Toxic Shock Cytokine Storm (2020) (4)
Man, mouse and Duffy genotype–phenotype‐specific pharmacokinetics of monocyte chemotactic protein‐1 (2004) (4)
Elevated serum transaminases in patients with acute coronary syndromes: Do we need a revision of exclusion criteria for clinical trials? (2021) (4)
Plasminogen activator inhibitor-1 4G/5G genotype and residual venous occlusion following acute unprovoked deep vein thrombosis of the lower limb: A prospective cohort study. (2017) (4)
Pharmacokinetic Modeling of Morphine’s Effect on Plasma Concentrations of Ticagrelor and Its Metabolite in Healthy Volunteers (2021) (4)
Regulation of histamine and diamine oxidase in patients undergoing orthotopic liver transplantation (2020) (3)
Prolonged Activated Partial Thromboplastin Time after Successful Resuscitation from Cardiac Arrest is Associated with Unfavorable Neurologic Outcome (2020) (3)
The platelet α2-integrin (GPIa) nucleotide-807 polymorphism is not associated with a risk for maternal–fetal human platelet antigen-5 incompatibility (2000) (3)
Oral NAloxone to overcome the moRphine effect in acute COronary syndrome patients treated with TICagrelor — NARCOTIC trial (2020) (3)
Antithrombin for severe sepsis? Try it again, but without heparin! (2006) (3)
Protease-Activated Receptors 1 and 3 are Differentially Expressed on Human Monocyte Subsets and are Upregulated by Lipopolysaccharide Ex Vivo and In Vivo (2019) (3)
Angiotensin II for the treatment of vasodilatory shock: enough data to consider angiotensin II safe? (2018) (3)
In vivo profile of the human leukocyte microRNA response to endotoxemia (2008) (3)
LpA-II:B:C:D:E: a new immunochemically-defined acute phase lipoprotein in humans (2018) (3)
Monitoring of ADAMTS13 in Patients with Thrombotic Thrombocytopenic Purpura: Prediction of Response to Therapy, Risk of Relapse, and Long- Term Outcome. (2008) (3)
Influence of proton pump inhibitors and VKORC1 mutations on CYP2C9‐mediated dose requirements of vitamin K antagonist therapy: a pilot study (2014) (3)
588 Optimization of schedule, route and adjuvant of therapeutic peptide vaccines against HCV (2006) (3)
PCSK9 decreases during experimental endotoxemia (2020) (3)
Assessing the influence of diurnal variations and selective Xa inhibition on whole blood aggregometry (2015) (3)
Selective glucocorticoid receptor modulation inhibits cytokine responses in a canine model of mild endotoxemia (2017) (3)
Can Sequential Coagulation Monitoring Predict Major Haemorrhage in Extremely Low Birth Weight Infants? (2018) (3)
[Consensus statement: Stroke prevention in nonvalvular atrial fibrillation in special consideration of the new direct oral anticoagulants]. (2014) (3)
Microvascular rarefaction in patients with cerebrovascular events (2021) (3)
Optimal duration and combination of antiplatelet therapies following percutaneous coronary intervention: A systematic review and meta-analysis. (2021) (3)
Influence of METHoxyflurane on ANtiplatelet Effect of ticagrelor in patients with unstable angina pectoris: Rationale and a protocol of a randomized clinical METHANE-SIRIO 4 study (2021) (3)
Pharmacokinetics of a Novel Anagrelide Extended‐Release Formulation in Healthy Subjects: Food Intake and Comparison With a Reference Product (2017) (3)
Different Types of Coagulase Are Associated With 28-Day Mortality in Patients With Staphylococcus aureus Bloodstream Infections (2020) (3)
Condensation of delta‐1‐piperideine‐6‐carboxylate with ortho‐aminobenzaldehyde allows its simple, fast, and inexpensive quantification in the urine of patients with antiquitin deficiency (2020) (3)
Fosinopril decreases levels of soluble vascular cell adhesion molecule-1 in Type II diabetic patients suffering from microalbuminuria (1998) (3)
[605] THERAPEUTIC PEPTIDE VACCINATION AGAINST CHRONIC HEPATITIS C VIRUS INFECTION (2007) (3)
Inhibition of tissue factor pathway inhibitor (TFPI) by ARC19499 improves clotting of hemophiliac blood (2010) (3)
Ristocetin-Induced Platelet Aggregation for Monitoring of Bleeding Tendency in Ibrutinib-Treated Patients with Chronic Lymphocytic Leukemia (2015) (3)
Safety of endotoxin challenge in healthy volunteers: bradycardia (2005) (2)
EFFECTS OF SHORT TERM STATIN PRE-TREATMENT AND SUBSEQUENT LOW DOSE ENDOTOXEMIA ON CIRCULATING ENDOTHELIAL PROGENITOR CELLS IN HEALTHY VOLUNTEERS (2007) (2)
Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis. (2017) (2)
Platelet glycoprotein Ibα polymorphisms and function evaluated by the platelet function analyzer PFA-100 in patients with lupus anticoagulant: the association with thromboembolic disease (2007) (2)
Thrombopoiesis Is Increased in Hyperthyroidisme (1998) (2)
Change of Hemoglobin Levels in the Early Post-cardiac Arrest Phase Is Associated With Outcome (2021) (2)
Effects of enalapril on disseminated intravascular thrombin formation during systemic inflammation. (2003) (2)
Subcutaneous injection of mRNA vaccines against severe acute respiratory syndrome coronavirus 2: an option for severe bleeding disorders or anticoagulated patients? (2021) (2)
Randomized Controlled Trial of Two Timepoints for Introduction of Standardized Complementary Food in Preterm Infants (2022) (2)
The systemic renin-angiotensin system in COVID-19 (2022) (2)
Disseminated Intravascular Coagulation Score Predicts Mortality in Patients with Liver Disease and Low Fibrinogen Level (2022) (2)
Association Between the Expression of MicroRNA-125b and Survival in Patients With Acute Coronary Syndrome and Coronary Multivessel Disease (2022) (2)
Predictors of Response to Erythropoietin in Autoimmune Hemolytic Anemia (2019) (2)
Low PCSK-9 levels Are Associated with Favorable Neurologic Function after Resuscitation from out of Hospital Cardiac Arrest (2020) (2)
The Toll-Like Receptor 4 Asp299Gly and Thr399Ile Polymorphisms Influence the Late Inflammatory Re- sponse in Human Endotoxemia, (2005) (2)
"Advances in thrombosis and haemostasis". (2003) (2)
DIC score predicts mortality in massive clot coagulopathy as a result of extensive pulmonary embolism: reply to a rebuttal (2010) (2)
Regional cortical development in very low birth weight infants with normal neurodevelopmental outcome assessed by 3D-ultrasound (2013) (2)
APRIL: A double-blind, placebo-controlled, randomized, Phase Ib/IIa clinical study of ApTOLL for the treatment of acute ischemic stroke (2023) (2)
Camostat Mesylate Versus Lopinavir/Ritonavir in Hospitalized Patients With COVID-19—Results From a Randomized, Controlled, Open Label, Platform Trial (ACOVACT) (2022) (2)
Sustained Complement C1s Inhibition with Sutimlimab in Patients with Cold Agglutinin Disease Results in Continued Efficacy during Part B of the Randomized Placebo-Controlled Phase 3 Cadenza Study (NCT03347422) (2022) (2)
The Thr715Pro single nucleotide polymorphism of P-selectin: does it really matter in cardiovascular or thrombotic disorders? (2004) (2)
Safety and Efficacy of the C1S Complement Inhibitor TNT009 in a FIRST-In-Human Trial (2017) (2)
Admission C-reactive protein concentrations are associated with unfavourable neurological outcome after out-of-hospital cardiac arrest (2021) (2)
Activation of calcium-dependent calmodulin by calcium(II)3(3,5-diisopropylsalicylate)6(H2O)6 decreases thrombin receptor activating peptide-induced P-selectin expression (2003) (2)
ANTI-IL-6 ANTIBODY CLAZAKIZUMAB IN LATE ANTIBODY-MEDIATED REJECTION – MOLECULAR REBOUND PHENOMENA UNDER IL-6 BLOCKADE? (2020) (2)
Performance of a Qualitative Point-of-Care Strip Test to Detect DOAC Exposure at the Emergency Department: A Cohort-Type Cross-Sectional Diagnostic Accuracy Study (2022) (2)
LUBAC and ABIN-1 Modulate TRAIL-Based NF-κB Induction in Human Embryonic Kidney 293 Cells (2018) (2)
Comparative proteomics reveals unexpected quantitative phosphorylation differences linked to platelet activation state (2019) (2)
Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Interim Results of the Phase 3 Cardinal Study Long-Term Follow-up (2020) (2)
Morphine decreases ticagrelor concentrations but not its effects: a randomized, double-blind, placebo-controlled trial (2015) (2)
“Protocol for a phase 2, randomized, double-blind, placebo-controlled, safety and efficacy study of dutogliptin in combination with filgrastim in early recovery post-myocardial infarction”: study protocol for a randomized controlled trial (2020) (2)
Chronic Inhibition of Complement C1s By TNT009 Produces Sustained, Complete Remission in Patients with Severe, Transfusion-Dependent Cold Agglutinin Disease (CAD) (2016) (2)
The VWF binding aptamer rondoraptivon pegol increases platelet counts and VWF/FVIII in type 2B von Willebrand disease (2022) (2)
The Anti Von Willebrand Factor Aptamer ARC1779 Prevents the Desmopressin-Induced Thrombocytopenia in VWD Type 2B. (2008) (1)
The EGF A61G polymorphism is associated with shorter disease-free period and survival in malignant melanoma (2006) (1)
Dexamethasone downregulates L-selectin in vitro and in vivo. (1998) (1)
Metabolome and lipidome derangements during a severe mast cell activation event in a patient with indolent systemic mastocytosis. (2021) (1)
von Willebrand Factor-binding aptamer rondoraptivon pegol as treatment for severe and non-severe hemophilia A. (2022) (1)
Heparin Blunts LPS-Induced Coagulation Activation Pernerstorfer (1999) (1)
GPIIb/IIIa inhibitors and aspirin Desmopressin antagonizes the in vitro platelet dysfunction induced by (2011) (1)
P1538: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK WASHOUT PERIOD IN PHASE 3 CARDINAL STUDY (NCT03347396) (2022) (1)
Functional Role of the Chemokine Binding Duffy Antigen Receptor Complex (DARC) in Human Inflammation In Vivo. (2006) (1)
Editorial on low-dose acetylsalicylic acid treatment and impact on short-term mortality in Staphylococcus aureus bloodstream infection: a propensity score-matched cohort study. (2016) (1)
Therapeutic Rationale and Clinical Development of TNT009, an Upstream Classical Pathway Inhibitor, for Cold Agglutinin Disease (2015) (1)
Soluble P-selectin in Diabetes (1999) (1)
Minimizing disasters during early drug development: A pressing need for an improved guidance (2006) (1)
Correction: Does Visceral Osteopathic Treatment Accelerate Meconium Passage in Very Low Birth Weight Infants?- A Prospective Randomized Controlled Trial (2017) (1)
The Effect of BIBT 986, a Novel Small Molecule Dual Inhibitor of Thrombin and Factor Xa, on Coagulation in a Model of Endotoxin Induced, Tissue Factor Triggered Coagulation Activation in Humans. (2006) (1)
The Aptamer ARC1779 Potently and Specifically Inhibits the Excessive von Willebrand Factor (vWF) Activity and vWF-Mediated Ex Vivo Platelet Function of Patients with Thrombotic Thrombocytopenic Purpura (TTP). (2007) (1)
TNT009, a monoclonal antibody inhibitor of C1s, induces a rapid and complete remission of anemia in primary cold agglutinin disease patients (2016) (1)
Corticosteroid Treatment Prevents Lipopolysaccharide-Induced Increase of ACE2 and Reduces Fibrin Degradation Products in Bronchoalveolar Lavage Fluid (2022) (1)
PII‐60 (2006) (1)
Short-chain methotrexate polyglutamate MTXPG2 as outcome parameter in rheumatoid arthritis (2010) (1)
Phase I Studies and First-In-Human Trials (2016) (1)
Add-on Prostaglandin E1 in Venovenous Extracorporeal Membrane Oxygenation: A Randomized, Double-blind, Placebo-controlled Pilot Trial. (2022) (1)
Thrombopoiesis is increased in hyperthyroidism. (1998) (1)
A randomized controlled trial on the effects of adding vitamin B 12 and folate (2006) (1)
S900 EVIDENCE BASED USE OF ERYTRHOPOIETIN IN PATIENTS WITH AUTOIMMUNE HEMOLYTIC ANEMIA: A MULTICENTER INTERNATIONAL STUDY (2019) (1)
Surface cooling for induction of mild hypothermia in conscious healthy volunteers (2010) (1)
Plasma Proteome Profiling: Widespread Oxidative Changes in Endotoxemia Correlate with Intravascular Tissue Factor Response. (2004) (1)
Strong Correlation of High Endogenous Plasma Levels of Tissue Factor Pathway Inhibitor (TFPI) with Poor Blood Clotting and Corrective Action of BAX 513 Under FVIII-Inhibited Conditions (2011) (1)
Nafamostat is a Potent Human Diamine Oxidase Inhibitor Possibly Augmenting Hypersensitivity Reactions during Nafamostat Administration (2022) (1)
Massive release of Th2 cytokines induced a cytokine storm during a severe mast cell activation event in an indolent systemic mastocytosis patient. (2022) (1)
Advanced pharmacodynamics of cangrelor in healthy volunteers: a dose-finding, open-label, pilot trial (2022) (1)
A model comparing how rapidly transfusion of solvent detergent plasma restores clotting factors versus infusion of albumin-saline. (2015) (1)
Influence of tedizolid on the cytokine response to the endotoxin challenge in healthy volunteers: a cross-over trial. (2022) (1)
Pharmacodynamics (PD) of clopidogrel in patients with acute coronary syndromes undergoing percutaneous interventions (PCI) (2005) (1)
353Evaluation of the pharmacokinetics and pharmacodynamics of subcutaneously administered dutogliptin for daily injection with granulocyte colony stimulating factor (G-CSF) for AMI (2018) (1)
Human diamine oxidase cellular binding and internalization in vitro and rapid clearance in vivo are not mediated by N-glycans but by heparan sulfate proteoglycan interactions. (2020) (1)
Influence of tiapride on platelet counts in healthy volunteers and patients with movement disorders (2003) (1)
Preterm Infants on Early Solid Foods and Iron Status in the First Year of Life—A Secondary Outcome Analysis of a Randomized Controlled Trial (2022) (0)
Su.56. Optimization of Schedule, Route and Adjuvant of Therapeutic Peptide Vaccines Against Hcv (2006) (0)
Influence of the Duffy genotype on pharmacokinetics and pharmacodynamics of recombinant monocyte chemoattractant protein (MCP-1) in vivo (2007) (0)
Glycosylation site Asn168 is important for slow in vivo clearance of recombinant human diamine oxidase heparin-binding motif mutants. (2022) (0)
associated with enhanced coagulation during human endotoxemia The single nucleotide polymorphism Ser128Arg in the E-selectin gene is (2013) (0)
Correction to: COVID-19 is not “just another flu”: a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, Austria (2021) (0)
Single, very low rituximab doses in healthy volunteers - a pilot and a randomized trial: implications for dosing and biosimilarity testing (2018) (0)
Corrigendum to “Patients With Severe Aortic Valve Stenosis and Impaired Platelet Function Benefit From Preoperative Desmopressin Infusion” [Ann Thorac Surg 91 (2011) 1420-1426] (2020) (0)
Su1722 Risk Factors Cannot Explain the Sex Specific Difference in Detection Rates of Colorectal Adenomas and Advanced Adenomas (2016) (0)
Human diamine oxidase is readily released from activated neutrophils ex vivo and in vivo but is rarely elevated in bacteremic patients (2020) (0)
Effects of Indomethacin on the l‐selectin Expression in Humans (2001) (0)
Reversal Strategy For Antagonizing The P2Y12-Inhibitor Ticagrelor By Platelet Concentrates (2013) (0)
Prolonged antithrombotic therapy in patients after acute coronary syndrome - a critical appraisal of current ESC guidelines (2020) (0)
Monitoring platelet activation with two different shear-dependent function tests: application of PFA-100 and the Impact-R ARA (2007) (0)
The aptamer ARC1779 is a potent and specific inhibitor of von Willebrand Factor-mediated ex vivo platelet function in ST-elevation and non-ST-elevation acute myocardial infarction (2008) (0)
Diamine oxidase knockout mice are not hypersensitive to orally or subcutaneously administered histamine (2022) (0)
Abstract 10981: Morphine Decreases Clopidogrel Concentrations and Effects: a Randomized, Double Blind, Placebo-Controlled Trial (2013) (0)
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology (2015) (0)
Expression Patterns of MiR-125a and MiR-223 and Their Association with Diabetes Mellitus and Survival in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome (2023) (0)
S285: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): 2-YEAR FOLLOW-UP FROM THE CARDINAL STUDY (2022) (0)
S905 LONG TERM INHIBITION OF COMPLEMENT C1S IN PATIENTS WITH COLD AGGLUTININ DISEASE: RESULTS FROM A NAMED PATIENT PROGRAM (2019) (0)
Preterm Infants on Early Solid Foods and Vitamin D Status in the First Year of Life—A Secondary Outcome Analysis of a Randomized Controlled Trial (2022) (0)
Quality criteria for Real-World Data in pharmaceutical research and healthcare decision making. An Austrian Expert Consensus (Preprint) (2021) (0)
Inhibition of Von Willebrand Factor (VWF) by ARC1779 Normalizes Von Willebrand Factor/FVIII Levels and Corrects Thrombocytopenia in VWD Type 2b Patients, (2011) (0)
New Technologies, Diagnostic Tools and Drugs (2009) (0)
MMP-8 Genotypes Influence the Inflammatory Response in Human Endotoxemia (2013) (0)
Homozygosity in the Single Nucleotide Polymorphism Ser128Arg in the E-Selectin Gene Is Associated with Recurrent Venous Thromboembolism. (2006) (0)
Methylnaltrexone to Reduce the Inhibitory Effects of Opioids on Drug Absorption. (2019) (0)
Nilotinib exerts proatherogenic and growth-inhibitory effects on endothelial cells: a potential mechanism underlying drug-related vasculopathy in Ph plus CML (2014) (0)
Nilotinib-induced vasculopathy : identification of vascular 1 endothelial cells as a primary target site 2 3 4 (2017) (0)
Monoclonal antibodies for treatment of cold agglutinin disease. (2023) (0)
Abnormal urine is detected by a specific pad of DOAC Dipstick near patient test strip (2021) (0)
Clinical usefulness of the novel DOAC Dipstick near patient test strip in emergency settings using semi-automatic DOASENSE Reader (2021) (0)
Surface cooling in combination with magnesium sulfate for induction of mild hypothermia in conscious healthy volunteers has only minor effect on platelet aggregation (2010) (0)
Sutimlimab provides clinically meaningful improvements in patient‐reported outcomes in patients with cold agglutinin disease: Results from the randomised, placebo‐controlled, Phase 3 CADENZA study (2022) (0)
Creation of a local 'fever' using an infrared lamp to cure a tooth abscess (2006) (0)
Immunoglobulin G production in COVID-19 - associations with age, outcome, viral persistence, inflammation and pro-thrombotic markers (2023) (0)
Regulation of histamine and diamine oxidase in patients undergoing orthotopic liver transplantation (2020) (0)
P668Aspirin for primary prevention of cardiovascular disease (2019) (0)
An improved diagnostic score for abdominal aortic aneurysms based on a comprehensive analysis of myeloid cell parameters (2018) (0)
European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on Antithrombotic Therapy for Vascular Diseases. (2023) (0)
EFFECT OF PROTON PUMP INHIBITORS ON CLINICAL OUTCOME IN PATIENTS TREATED WITH CLOPIDOGREL: A SYSTEMATIC REVIEW AND META-ANALYSIS (2010) (0)
Corrigendum to "Characterization of recombinant human diamine oxidase (rhDAO) produced in Chinese Hamster Ovary (CHO) cells" [J. Biotechnol. 227 (2016) 120-130]. (2016) (0)
Sutimlimab Provides Sustained Improvements in Patient-Reported Outcomes and Quality of Life in Patients with Cold Agglutinin Disease: Open-Label Extension of the Randomized, Phase 3 Cadenza Study (2022) (0)
Simple, fast and inexpensive quantification of glycolate in the urine of patients with primary hyperoxaluria type 1 (2023) (0)
Functional capillary impairment in patients with ventricular assist devices (2019) (0)
Mechanism of action of drotrecogin alfa activated (rhAPC) (2004) (0)
TNT009 Prevents Erythrocyte C3 Fragment Opsonization and Rescues Reticulocytes from Destruction in Patients with Cold Agglutinin Disease (2016) (0)
985: DEXAMETHASONE REDUCES SYSTEMIC INFLAMMATION BUT ONLY MINIMALLY DECREASES INTERLEUKIN-6 SECRETION INTO LUNG FOLLOWING BRONCHIAL ENDOTOXIN INSTILLATION TO HEALTHY VOLUNTEERS (2012) (0)
Aspirin (2004) (0)
960: DEXAMETHASONE INHIBITS ENDOTOXIN-INDUCED CLOTTING BY BLUNTING PROTEIN EXTRAVASATION IN HUMAN LUNGS (2016) (0)
THREE-MONTH RESULTS OF A PHASE 2 TRIAL EVALUATING CLAZAKIZUMAB IN LATE ANTIBODY-MEDIATED REJECTION – EARLY IMPACT OF IL-6 BLOCKADE ON DONOR-SPECIFIC ANTIBODY LEVELS, REJECTION MORPHOLOGY AND GENE EXPRESSION (2020) (0)
Surrogate markers to monitor efficacy of anticoagulants or antiplatelet drugs in atrial fibrillation. (2002) (0)
New drugs and directions (2005) (0)
Highly Procoagulant Extracellular Vesicles in Amniotic Fluid (2016) (0)
Anti-interleukin-6 Antibody Clazakizumab in Antibody-mediated Renal Allograft Rejection: Accumulation of Antibody-neutralized Interleukin-6 Without Signs of Proinflammatory Rebound Phenomena (2022) (0)
Granulocyte colony-stimulating factor and cytokine release. (2000) (0)
Leukocyte scintigraphy with 99mTc-exametazime-labeled leukocytes is not useful for follow-up of systemic vasculitis. (2002) (0)
Effect of therapeutic mild hypothermia initiated by cold fluids after cardiac arrest on haemostasis as measured by thrombelastography (2008) (0)
Pregnancy-associated diamine oxidase originates from extravillous trophoblasts and is decreased in early-onset preeclampsia (2018) (0)
Upregulation of cytokine mRNA in circulating leukocytes during human endotoxemia (2017) (0)
P531Mitochondria of parental cells control the capacity of monocyte-derived microvesicles to activate endothelial cells (2018) (0)
A bedside urine based test strip on identifying anticoagulation with direct oral anticoagulants at a high-volume emergency department – a diagnostic test accuracy study (2021) (0)
“Low-Level” Carbon Monoxide Administration May Carry Risk (2005) (0)
WITHDRAWN: Extraordinary apolipoprotein oxidation in chronic hepatitis C and liver cirrhosis. (2007) (0)
Inflammatory Conditions Migration Inhibitory Factor Ameliorates Conformational Isoform of Macrophage Selective Targeting of a Disease-Related (2015) (0)
Anti-interleukin-6 Antibody Clazakizumab in Antibody-mediated Kidney Transplant Rejection: Effect on Donor-derived Cell-free DNA and C-X-C Motif Chemokine Ligand 10 (2022) (0)
Delayed effect of desmopressin on circulating neutrophils and monocytes. (1996) (0)
Response to Letter by Tho (2009) (0)
Pro-Atherogenic and Anti-Angiogenic Effects of Nilotinib on Endothelial Cells: A Potential Mechanism to Explain Vasculopathies in Cml Patients Treated With Nilotinib (2014) (0)
Trial in Progress: Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients with Cold Agglutinin Disease (CASCADE) (2022) (0)
Myeloid but not epithelial tissue factor exerts protective anti-inflammatory properties in acid aspiration-induced acute lung injury. (2017) (0)
2.P.362 Morning hypercoagulability and hypofibrinolysis: diurnal variations in circulating activated factor VII, prothrombin fragment F1+2, and plasmin-plasmin inhibitor-complex (1997) (0)
Micellar Curcumin: Pharmacokinetics and Effects on Inflammation Markers and PCSK‐9 Concentrations in Healthy Subjects in a Double‐Blind, Randomized, Active‐Controlled, Crossover Trial (2022) (0)
Effect of endotoxin on retinal erythrocyte and leukocyte flux in healthy humans. (2004) (0)
Effects of Strong P2Y12 Receptor Inhibition by Prasugrel on Platelet Inhibition During Endotoxemia: A Randomized Controlled Trial (2011) (0)
Characterization of recombinant human diamine oxidase produced in Chinese Hamster Ovary cells (2016) (0)
Effects of neuropeptide Y and vasoactive intestinal peptide on human venous smooth muscle in vivo (1994) (0)
Hyperthyroidism enhances platelet plug formation (2006) (0)
Abstract 12868: Morphine Decreases Ticagrelor Concentrations but Not Its Effects: A Randomized, Double-Blind, Placebo-Controlled Trial (2015) (0)
Author Correction: Admission C-reactive protein concentrations are associated with unfavourable neurological outcome after out-of-hospital cardiac arrest (2021) (0)
that demarginate during acute maximal exercise Expression of the cell adhesion molecules on leukocytes (2015) (0)
Author response: Heparin-binding motif mutations of human diamine oxidase allow the development of a first-in-class histamine-degrading biopharmaceutical (2021) (0)
Biomarkers for differentiation of coronavirus disease 2019 or extracorporeal membrane oxygenation related inflammation and bacterial/fungal infections in critically ill patients: A prospective observational study (2022) (0)
Correction (1989) (0)
P176An improved diagnostic score for abdominal aortic aneurysms based on a comprehensive analysis of myeloid cell parameters (2018) (0)
Acetylsalicylic acid decreases clotting in combination with enoxaparin during haemodialysis in vitro (2018) (0)
PP078—Comparison of a new elisa-based with the flow cytometric assay for vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation to assess P2Y12-inhibition after ticagrelor intake (2013) (0)
Population-based incidence of all-cause anaphylaxis and its development over time: a systematic review and meta-analysis (2023) (0)
1293: TRANEXAMIC ACID RESTORES CLOTTING IN THROMBUS ASSOCIATED HYPERFIBRINOLYSIS WITH OVERT BLEEDINGS (2014) (0)
Adenosine diphosphate induced platelet aggregation is markedly increased in patients with ischemia-triggered cardiac arrest achieving ROSC (2010) (0)
Natural IgM Against Oxidation-Specific Epitopes Inhibit Microvesicle-Driven Coagulation (2016) (0)
Acquired Von Willebrand Factor Deficiency Caused By Left Ventricular Assist Devices Is Adamts-13 Dependent (2013) (0)
Sustained hematologic remission after discontinuation of sutimlimab treatment in patients with cold agglutinin disease. (2022) (0)
Multi-phasic life-threatening anaphylaxis refractory to epinephrine managed by extracorporeal membrane oxygenation (ECMO): A case report (2022) (0)
445 Function and phenotype of peptide-vaccine induced HCV specific CD8+ T cells vs. acute and chronic hepatitis C (2006) (0)
Corrigendum to “Patients With Severe Aortic Valve Stenosis and Impaired Platelet Function Benefit From Preoperative Desmopressin Infusion” [Ann Thorac Surg 91 (2011) 1420-1426] (2020) (0)
Abstract 2223: Shear Induced Platelet Function Is Highly Increased In Patients With Cardiac Arrest Undergoing Cardio-pulmonary Resuscitation (CPR) (2007) (0)
Quality Criteria for Real-world Data in Pharmaceutical Research and Health Care Decision-making: Austrian Expert Consensus (2021) (0)
P1665: WHOLE-BLOOD ROTATIONAL THROMBOELASTOMETRY (ROTEM) AS A DIAGNOSTIC TOOL IN PATIENTS WITH BLEEDING OF UNKNOWN CAUSE (BUC) (2022) (0)
Oc025—Reversal Strategy In Antagonizing The P2y12-Inhibitor Ticagrelor (2013) (0)
VWF as a Prognostic Marker for Coronary Artery Disease in Initially Healthy Subjects (2008) (0)
The Authors' reply (2011) (0)
The Pharmacodynamic Effects of Rituximab at Very Low Doses (2017) (0)
Long term immunogenicity following a booster dose of the inactivated Japanese encephalitis vaccine IXIARO®, IC51 (2010) (0)
453: MASSIVE BLEEDING ENSUES HYPERFIBRINOLYTIC DISSEMINATED INTRAVASCULAR COAGULATION IN DROWNING VICTIMS (2014) (0)
Targeted temperature management after cardiac arrest is associated with reduced metabolism of pantoprazole - A probe drug of CYP2C19 metabolism. (2021) (0)
OC 025 — reVerSAl STrATegy iN ANTAgONiziNg The p 2 y 12-iNhibiTOr (2013) (0)
A multicentre, patient- and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided immunosuppression in kidney transplant recipients in the first year after transplantation: TTVguideIT (2023) (0)
Endovascular thrombectomy with or without intravenous thrombolysis in large-vessel ischemic stroke: A non-inferiority meta-analysis of 6 randomised controlled trials. (2023) (0)
Extraordinary apolipoprotein oxidation in chronic and liver (2007) (0)
LpA-II:B:C:D:E: a new immunochemically-defined acute phase lipoprotein in humans (2018) (0)
Randomized, double-blind, placebo controlled trial of RHU-EPO to improve platelet count and platelet function in alcoholic cirrhotics with thrombocytopenia (2002) (0)
Effect of the human endotoxin challenge on tedizolid tissue penetration (2022) (0)
Diamine oxidase in pregnancy – An old acquaintance exclusively released from an unexpected source (2016) (0)
Analysis of Aptamer Concentrations in Cynomolgus Macaque Plasma and in the Serum Stability Study (2012) (0)
Anticoagulant and Anti-Inflammatory Effects of Recombinant Human Antithrombin in Man after LPS Challenge. (2005) (0)
Prevalence and clinical impact of reduced FXII activity in patients receiving extracorporeal membrane oxygenation (2021) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Bernd Jilma?

Bernd Jilma is affiliated with the following schools:

Medical University of Vienna
University of Florida
University of Barcelona
University of Vienna
University of Duisburg-Essen

Bernd Jilma's Academic­Influence.com Rankings

Bernd Jilma's Degrees

Similar Degrees You Can Earn

Why Is Bernd Jilma Influential?

Bernd Jilma's Published Works

Published Works

What Schools Are Affiliated With Bernd Jilma?

Bernd Jilma's AcademicInfluence.com Rankings